National Institute of Cancer - INCA, Brazil, Rio de Janeiro, Brazil
I do not have any relevant financial / non-financial relationships with any proprietary interests.
L-2J - Cost-utility of Nivolumab for Treatment of Head and Neck Cancer from a Brazilian Public Health System Perspective
Monday, August 23, 20216:30 PM – 7:30 PM US Eastern Time